SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-11-012684
Filing Date
2011-02-24
Accepted
2011-02-24 12:21:32
Documents
4
Period of Report
2011-02-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd302733.htm 8-K 15113
2 PRESS RELEASE, DATED FEBRUARY 22, 2011, TITLED "DYNAVAX REPORTS NEW PHASE 1A AND rrd302733_34260.htm EX-99.1 7086
3 PRESS RELEASE, DATED FEBRUARY 22, 2011, TITLED "DYNAVAX REPORTS ADDITIONAL POSIT rrd302733_34261.htm EX-99.2 6649
4 PRESS RELEASE, DATED FEBRUARY 23, 2011, TITLED "DYNAVAX'S TWO PHASE 3 HEPLISAV T rrd302733_34262.htm EX-99.3 7134
  Complete submission text file 0001181431-11-012684.txt   37495
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 11634981
SIC: 2834 Pharmaceutical Preparations